Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00669292
What this trial is testing

PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Wakayama Medical University 29
Early research (Phase 1)Study completedNCT02362217
What this trial is testing

Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination

Who this might be right for
Hepatitis C InfectionHIV Infection
University of Oxford 33
Testing effectiveness (Phase 2)Ended earlyNCT05357898
What this trial is testing

Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 20
Large-scale testing (Phase 3)Study completedNCT01991899
What this trial is testing

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Who this might be right for
MeaslesMumpsRubella+1 more
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,560
Large-scale testing (Phase 3)Study completedNCT00226499
What this trial is testing

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

Who this might be right for
VaricellaChickenpox Vaccines
GlaxoSmithKline 5,803
Testing effectiveness (Phase 2)Looking for participantsNCT03942328
What this trial is testing

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Stage III Hepatocellular Carcinoma AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8+3 more
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00179309
What this trial is testing

Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI) 48
Large-scale testing (Phase 3)Study completedNCT00316147
What this trial is testing

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

Who this might be right for
DiphtheriaAcellular PertussisTetanus+3 more
GlaxoSmithKline 224
Testing effectiveness (Phase 2)WithdrawnNCT03014804
What this trial is testing

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Giant Cell GlioblastomaGliosarcomaOligodendroglioma+2 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00111514
What this trial is testing

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

Who this might be right for
Leishmaniasis, Mucocutaneous
Access to Advanced Health Institute (AAHI) 48
Testing effectiveness (Phase 2)Study completedNCT00006291
What this trial is testing

Safety and Effectiveness of Adding Either an HIV Vaccine, Interleukin-2, or Both to a Patient's Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Looking for participantsNCT07095868
What this trial is testing

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

Who this might be right for
Selected Types of Solid Tumor
Everest Medicines (Beijing) Co., Ltd. 94
Early research (Phase 1)UnknownNCT03784040
What this trial is testing

Nivolumab, Ipilimumab and OTSGC-A24 Therapeutic Peptide Vaccine in Gastric Cancer - a Combination Immunotherapy Phase Ib Study.

Who this might be right for
Gastric Cancer
National University Hospital, Singapore 40
Not applicableLooking for participantsNCT07423169
What this trial is testing

Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer

Who this might be right for
Lung AdenocarcinomaBulky TumorsUnresectable Cancer
Karl Landsteiner University of Health Sciences 10
Testing effectiveness (Phase 2)Study completedNCT00133445
What this trial is testing

Pentavalent DTaP-Hep B-IPV

Who this might be right for
DiphtheriaHepatitis BPoliomyelitis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 5
Testing effectiveness (Phase 2)UnknownNCT00589186
What this trial is testing

Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Centre, Singapore 35
Early research (Phase 1)Looking for participantsNCT06184542
What this trial is testing

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Who this might be right for
DiphtheriaTetanusPertussis
Institute of Medical Biology, Chinese Academy of Medical Sciences 460
Testing effectiveness (Phase 2)Study completedNCT02099994
What this trial is testing

Safety & Immunogenicity of HIV Vaccines in Healthy Kenyan Adults

Who this might be right for
AIDS
University of Oxford 72
Early research (Phase 1)Ended earlyNCT01493154
What this trial is testing

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Not applicableStudy completedNCT00694551
What this trial is testing

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 29
Next Page
85